The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.

Takuma HigurashiJun ArimotoKeiichi AshikariTomohiro TakatsuNoboru MisawaTsutomu YoshiharaTetsuya MatsuuraAkiko FuyukiHidenori OhkuboAtsushi Nakajima

Published in: BMC cancer (2020)

This trial has been registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry as UMIN000029926 . Registered 10 November 2017.

Keyphrases

open label
clinical trial
phase ii
phase iii
study protocol
endothelial cells
double blind
phase ii study
healthcare
randomized controlled trial
induced pluripotent stem cells
combination therapy
squamous cell carcinoma
radiation therapy
replacement therapy
smoking cessation